Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSigmaroc. Regulatory News (SRC)

Share Price Information for Sigmaroc. (SRC)

Share Price is delayed by 15 minutes
Get Live Data
120.90    2.10 (1.77%)
Bid:
121.30
Ask:
121.50
Spread: 0.20 (0.165%)
Market Cap: £1.34b
SRC Live PriceLast checked at - London Stock Exchange

Intraday Sigmaroc. Share Chart

Trading Update

29 Jul 2022 07:00

RNS Number : 1517U
SigmaRoc PLC
29 July 2022
 

29 July 2022

 

(EPIC: SRC / Market: AIM / Sector: Construction Materials)

 

SIGMAROC PLC

 ('SigmaRoc', the 'Group' or the 'Company')

 

Trading update H1 2022 - Positive trading momentum

 

SigmaRoc, the specialist quarried materials group, is pleased to announce strong H1 2022 trading, with good momentum carried into H2 2022.

 

Highlights:

 

- Strong first half of 2022, demonstrating the effectiveness of the Group's diversified model;

- H1 revenue of £248m, up 18% over 2021 on an adjusted like-for-like basis;

- H1 underlying EBITDA of £48m, up 6% over 2021;

- Underlying EPS over 3.6p, up approximately 35% over the prior period;

- Continued good cash generation, with leverage within the Group's target range;

- Diversified market profile and good demand leave the Group well placed to deliver the Board's expectations for 2022.

 

The Group delivered H1 revenue of £248m, representing an 18% like-for-like increase over the same period last year. First half EBITDA was £48m, ahead 6% on a like-for-like basis over H1 2021, giving an 19.2% EBITDA margin for the period which benefited from the effectiveness of contractual pass through mechanisms, dynamic pricing and continued cost management.

 

Underlying EPS for the half year was over 3.6p, representing an increase of more than 35% from H1 2021, demonstrating the value accretion from the Nordkalk acquisition and effectiveness of the Group's operational improvement programmes. The Group has continued to generate cash and following the completion of the Johnston acquisition in Q1 2022, leverage has reduced to 2.2x at the end of H1 2022, within the Group's target range.

 

Outlook

 

Trading in the early part of H2 2022 has started well, with the Group benefitting from its broad end market and geographical diversification. Demand remains good both for housing and infrastructure related demand, as well as for industrial minerals. The Group has successfully dealt with the various supply chain and inflationary headwinds in H1 2022, with further improvement initiatives planned for H2 2022.

 

The Group expects to publish its 2022 interim results by 12 September 2022.

 

Max Vermorken, CEO of SigmaRoc, commented:

 

"To state the obvious this was a first half unlike any other, yet the Group performed extremely well. Input cost increases were managed and further cost reduction initiatives were implemented. We closed H1 2022 with a strong performance and remain encouraged by the demand outlook in all segments for the months ahead. Our focus remains squarely on developing our Group in terms of products and geography and we remain very confident in delivering good financial and strategic progress both in the current year and over the medium term."

 

 

Information on the Company is available on its website, www.sigmaroc.com.

 

SigmaRoc plc

Max Vermorken

 

Tel: +44 (0) 207 002 1080

Liberum Capital (Co-Broker and Nominated Adviser)

Neil Patel / Jamie Richards / Ben Cryer

Tel: +44 (0) 203 100 2000

 

 

Peel Hunt (Co-Broker)

Mike Bell / Ed Allsopp

 

Tel: +44 (0) 20 7418 8900

Investor Relations

Dean Masefield

Tel: +44 (0) 207 002 1080

ir@sigmaroc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPPUGAMUPPGAR
Date   Source Headline
29th Dec 20207:00 amRNSHolding(s) in Company
22nd Dec 20207:00 amRNSNew expanded £125 million Credit Facility
15th Dec 20204:20 pmRNSHolding(s) in Company
15th Dec 202010:00 amRNSHolding(s) in Company
9th Dec 20203:25 pmRNSResults of Placing
9th Dec 20207:01 amRNSProposed Placing
9th Dec 20207:00 amRNSTrading update
22nd Sep 20207:00 amRNSAcquisition of leading quarrying group GDH
17th Sep 20205:00 pmRNSHolding(s) in Company
8th Sep 20207:00 amRNSInvestor Presentation
7th Sep 20207:00 amRNSInterim Results
3rd Sep 202011:30 amRNS2020 interim results: investor & analyst call
1st Sep 20207:00 amRNSAcquisition of leading quarrying group GDH
10th Aug 20206:00 pmRNSHolding(s) in Company
6th Aug 20208:30 amRNSHolding(s) in Company
4th Aug 202011:36 amRNSHolding(s) in Company
31st Jul 20207:00 amRNSDirector and PDMR Dealings
30th Jul 20207:00 amRNSTrading update
3rd Jul 20208:05 amRNSCDH agrees roadworks co-funding with Walloon Govt
9th Jun 20207:00 amRNSTrading Update
3rd Jun 202011:30 amRNSDirector and PDMR Dealings
18th May 20202:45 pmRNSResults of AGM
20th Apr 20207:01 amRNSBoard appointments
20th Apr 20207:00 amRNSAnnual results for year ended 31 December 2019
14th Apr 20207:00 amRNSHolding(s) in Company
9th Apr 202010:00 amRNSHolding(s) in Company
9th Apr 20209:15 amRNSAppointment of joint broker & FY2019 results call
6th Apr 20207:00 amRNSOperational Update
2nd Apr 202010:00 amRNSHolding(s) in Company
27th Mar 202012:05 pmRNSHolding(s) in Company
27th Mar 202012:00 pmRNSHolding(s) in Company
25th Mar 20207:00 amRNS2019 Results and Coronavirus Update
3rd Mar 20209:30 amRNSDirector and PDMR Dealings
2nd Jan 202010:38 amRNSDirector and PDMR Dealings
31st Dec 20199:16 amRNSGrant of Options and PDMR Dealing
19th Dec 20197:00 amRNSCredit Facility and Advisory Board
24th Oct 201911:24 amRNSHolding(s) in Company
24th Oct 201911:21 amRNSHolding(s) in Company
24th Oct 20199:05 amRNSHolding(s) in Company
23rd Oct 20195:00 pmRNSHolding(s) in Company
18th Oct 20195:10 pmRNSHolding(s) in Company
17th Oct 20195:48 pmRNSHolding(s) in Company
17th Oct 20194:10 pmRNSHolding(s) in Company
16th Oct 20192:21 pmRNSPDMR Dealings
15th Oct 20195:45 pmRNSSuccessful Completion of Placing
15th Oct 20191:52 pmRNSProposed Acquisition and Proposed Placing
10th Oct 20192:00 pmRNS£5.5m cash disposal of non-core land
30th Sep 20197:00 amRNSHalf-year Report
27th Sep 201911:15 amRNSResult of GM
11th Sep 20197:00 amRNSAcquisition, proposed board appointment & GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.